Here's what's in our Synthetic Biology market report
In our synthetic biology market deck, you will find everything you need to understand the market
SUMMARY
Our Synthetic Biology market report is a 210+ page research deck covering the market from definition and sizing through technologies, companies, funding, customers, business models, risks, and startup strategies.
The report is organized into 12 sections, but the useful part is how they connect. Market size is tied back to a clear definition, technologies are examined alongside manufacturing constraints, and company activity is connected to funding and commercial models.
We use a relatively strict definition of synthetic biology. Designed DNA, genetic circuits, engineered organisms, biofoundries, lab automation, and synbio-enabled products belong in the core market, while conventional biotechnology or traditional fermentation do not automatically qualify.
That definition changes the market-size answer quite a lot. Rather than choosing the largest published forecast, we build the estimate from relevant segments and compare it with outside research so readers can see why different sources disagree.
One recurring theme in the report is that scientific success is only part of the job. Scale-up, yield consistency, downstream processing, manufacturing capacity, input costs, and commercial production can become bigger problems after the biology already works.
The customer analysis deliberately asks who actually pays. Pharmaceutical companies, manufacturers, agriculture businesses, research organizations, and materials buyers can have very different reasons for adopting synthetic biology, so a large theoretical market does not automatically mean an easy commercial opportunity.
Funding and company activity are used as evidence of where conviction still exists. Recent rounds, investor behavior, company grids, and market maps help show which parts of synthetic biology remain crowded, which themes have cooled, and where serious companies are still emerging.
The business-model section is especially important because synthetic biology companies can have completely different economics. Research tools may generate revenue quickly, while platform, materials, therapeutics, or manufacturing businesses can depend for years on partnerships, milestones, licensing, grants, or outside capital.
The report also spends meaningful space on failure rather than only highlighting winners. Long development cycles, weak first products, expensive manufacturing, regulatory friction, and the jump from pilot success to repeatable commercial production show up repeatedly in struggling companies.
This is primarily a global industry report rather than a country-by-country database. It is delivered digitally in English, currently starts at $49 as a one-time purchase, and is designed for founders, investors, and strategy teams that need a structured view of what is happening across the Synthetic Biology market.
This market map, featured in our synthetic biology market deck, highlights top companies and startups in the synthetic biology market
Is the latest Synthetic Biology market report actually up to date?
Yes. The latest New Market Pitch Synthetic Biology market report is regularly refreshed with new company activity, funding, technology shifts, and other market signals.
Synthetic biology moves quickly, especially around new platforms, production technologies, funding rounds, and commercialization. We update the parts of the report that can age fastest instead of leaving buyers with a static snapshot.
The report focuses on what is happening in the Synthetic Biology market now, including which technologies are moving toward real production, where scale-up is still difficult, what investors are funding, and which companies are gaining attention.
What exactly is inside the Synthetic Biology market report?
The New Market Pitch Synthetic Biology market report is a 210+ page deck with 12 sections covering market size, technologies, companies, funding, customers, business models, risks, and startup strategies.
We start by defining what we count as synthetic biology. From there, the report covers the size of the opportunity, customer problems, technologies and infrastructure, ways companies make money, growth drivers, funding activity, major players, and the reasons some synthetic biology startups struggle.
We built the report for people making an actual decision around the market, including founders looking for an opportunity, investors researching a company, and strategy teams trying to understand competitors or adjacent markets.
| Report section | What it covers |
|---|---|
| Market Definition | What we count as synthetic biology |
| Market Opportunity | Why companies are entering the market |
| Market Size | Current size and future potential |
| Pain Points | Problems customers are trying to solve |
| Tech & Infra | Technologies and infrastructure behind the market |
| Value Creation | How companies make money |
| Market Challenges | Commercial and operational risks |
| Growth Drivers | What could push adoption higher |
| Investor Bets | Funding activity and investor interest |
| Top Players | Startups and established companies |
| Startup Killers | Common reasons companies fail |
| Startup Strategies | Approaches stronger companies are using |
As this chart shows, and as featured in our synthetic biology market deck, search interest in gene editing has grown significantly
What does the report actually count as Synthetic Biology?
The Synthetic Biology market report uses a fairly strict definition built around engineered biological systems, designed DNA, genetic circuits, engineered organisms, and the tools used to create them.
That includes specialized synthetic biology software and tools, biofoundries, lab automation, and products in areas such as health, food, agriculture, chemicals, and materials when synthetic biology is central to how the product is made.
We keep conventional biotechnology, ordinary pharmaceuticals, traditional fermentation, and basic GMO products outside the core market when modern synthetic biology techniques are only a small part of the story.
The definition is important when comparing market-size numbers because different research firms can produce very different estimates simply by counting different things.
| Included in our Synthetic Biology definition | Usually outside the core definition |
|---|---|
| Designed DNA and genetic circuits | Conventional biotechnology |
| Engineered organisms | Traditional pharmaceuticals |
| Synthetic biology software and tools | Basic GMO products |
| Biofoundries and lab automation | Traditional fermentation |
| Synbio-enabled health products | Bio-based products with little synbio involvement |
| Synbio-enabled food and agriculture | |
| Synbio-enabled chemicals and materials |
If you want more recent data on this point, please see our latest synthetic biology market report.
Does the Synthetic Biology report include market size and forecasts?
Yes. The Synthetic Biology market report includes our estimate of the current market size, expected growth, and how large the opportunity could become.
We build the estimate from the bottom up rather than copying one large number from another market report. We define what belongs in the market, estimate the relevant segments, and compare the result with outside industry estimates.
That gives buyers something they can actually inspect. If two sources say the Synthetic Biology market is worth very different amounts, the report helps explain where those differences come from instead of simply choosing the biggest forecast.
This chart, featured in our synthetic biology market deck, illustrates yearly VC funding for synthetic biology startups
Where does the Synthetic Biology market data come from?
The Synthetic Biology market report uses company filings, funding databases, public datasets, company announcements, expert input, and existing industry research.
We also build some of the analysis ourselves, especially around market sizing and market structure. When we do that, we show the assumptions behind the estimate so the reader can see how we got there.
Synthetic biology data gets messy quickly because market definitions vary so much. We try to keep the numbers tied to a clear definition of the market rather than mixing biotech, fermentation, pharmaceuticals, and synthetic biology into one oversized category.
Does the report cover the latest Synthetic Biology technologies?
Yes. The Synthetic Biology market report covers the technologies and infrastructure that are shaping the market now, including gene editing, protein design, biofoundries, automation, and biomanufacturing platforms.
We look at both the tools used to engineer biology and the infrastructure needed to turn those designs into products.
That includes areas such as engineered organisms, lab automation, protein design, biomanufacturing platforms, and newer tools that can speed up design-build-test cycles.
We also look at whether these technologies are getting closer to commercial use. A technology can work beautifully in a lab and still run into serious problems when a company tries to manufacture at scale.
This chart, featured in our synthetic biology market deck, shows how Twist Bioscience is capturing share in synthetic biology
Does the Synthetic Biology report include startups and established companies?
Yes. The Synthetic Biology market report includes emerging startups as well as larger and more established companies across the sector.
The company coverage includes names such as Ginkgo Bioworks, Mammoth Biosciences, and Twist Bioscience alongside younger companies working on pharmaceuticals, materials, food, agriculture, biofuels, and other applications.
We use company grids and market maps to show where companies sit in the ecosystem and where activity is becoming crowded.
That makes the report useful when you are looking for competitors, investment targets, potential partners, or areas where very few serious companies have appeared yet.
Does the Synthetic Biology report cover recent funding rounds?
Yes. The Synthetic Biology market report tracks recent funding rounds and shows which companies and technologies investors are backing now.
We use funding activity to see where money is actually moving. The report looks at companies raising capital, the types of products they are building, and the themes investors keep coming back to.
Recent rounds involving companies such as Antheia also help us see where investors still have conviction even after funding became harder for many synthetic biology businesses.
It is more useful than a funding database alone. The recent deals tell us something about what investors are still willing to finance.
If you want more recent data on this point, please see our latest synthetic biology market report.
This chart, featured in our synthetic biology market deck, illustrates yearly funding for synthetic biology startups
Does the report show which investors are betting on Synthetic Biology?
Yes. The Synthetic Biology market report looks at investor activity alongside recent company fundraising so buyers can see where capital is concentrating.
We examine which types of synthetic biology companies are still attracting money, which technologies are getting funded, and which themes have cooled down.
That can be useful for founders trying to understand what investors are interested in and for investors comparing their own thesis with the rest of the market.
Funding changes quickly in synthetic biology, so this is one of the sections we keep particularly close to current market activity.
Does the report compare Synthetic Biology business models?
Yes. The Synthetic Biology market report compares how companies make money through product sales, licensing, research services, milestones, royalties, grants, and CDMO-style revenue.
The economics can look completely different from one synthetic biology company to another.
A company selling a research tool can reach revenue much faster than a business spending years developing a new material or biological product. A platform company may also depend heavily on partnerships, milestones, or licensing before direct product revenue becomes meaningful.
We compare these models so buyers can see how companies turn the science into revenue and where the commercial model may become difficult.
This chart, featured in our synthetic biology market deck, compares the main business model options for synthetic biology platforms
Does the report show who actually buys Synthetic Biology products?
Yes. The Synthetic Biology market report identifies the main customer groups and the problems that could make them pay for synthetic biology products or services.
Those customers include pharmaceutical companies, manufacturers, agriculture businesses, research organizations, and companies looking for new materials or production methods.
We connect the customer to the problem being solved. That helps separate a technically impressive idea from something with a clear buyer on the other side.
For someone researching a startup opportunity, this section is especially useful because the market can look huge until you ask who signs the contract and why.
Does the report cover scale-up and manufacturing problems in Synthetic Biology?
Yes. The Synthetic Biology market report goes into the scale-up and manufacturing problems that can kill an otherwise promising company.
We look at long development cycles, expensive scale-up, inconsistent yields, downstream processing, biomanufacturing capacity, input constraints, and the gap between a successful pilot and reliable commercial production.
A lot of synthetic biology risk shows up after the science has already worked. The company then has to produce enough volume, at the right quality, with economics that customers can accept.
The report also covers the conditions that would make the market easier to scale, including better infrastructure, faster R&D cycles, stronger manufacturing capacity, and more reliable commercialization pathways.
If you want more recent data on this point, please see our latest synthetic biology market report.
This chart, featured in our synthetic biology market deck, illustrates the share of revenue generated by each customer segment in the synthetic biology market
Does the Synthetic Biology report cover regulation too?
Yes. The Synthetic Biology market report covers regulation where it affects timelines, costs, market access, and the ability to commercialize a product.
The regulatory path depends heavily on what the company is building. A research tool, food ingredient, therapeutic input, agricultural product, and engineered material can each face very different requirements.
We therefore treat regulation as part of the commercial analysis rather than as a generic legal overview.
For buyers comparing synthetic biology opportunities, the useful question is usually how much regulation could slow a company down, increase its capital needs, or make the route to market harder.
Does the report explain why Synthetic Biology startups fail?
Yes. The Synthetic Biology market report includes a dedicated section on the recurring reasons synthetic biology startups fail or get stuck.
We looked at failed and struggling companies to identify patterns that show up again and again.
Some teams optimize the organism and underestimate downstream processing. Others treat a successful pilot as proof that customers will buy at scale. Platform companies can also spend years building broad technical capabilities without finding a strong first product.
The report brings those patterns together with the bigger pressures in the market, including long R&D cycles, heavy capital needs, manufacturing problems, regulation, and dependence on outside partners.
If you want more recent data on this point, please see our latest synthetic biology market report.
This chart, featured in our synthetic biology market deck, shows how gene therapy technology has evolved over time
Does the report cover the main Synthetic Biology submarkets?
Yes. The Synthetic Biology market report covers both enabling technologies and major application areas instead of treating synthetic biology as one single market.
On the technology side, we look at tools, software, engineered biological systems, biofoundries, automation, and manufacturing infrastructure.
On the application side, the report includes areas such as health, food, agriculture, chemicals, materials, pharmaceuticals, biofuels, and alternative proteins when synthetic biology plays a central role.
The differences between these submarkets can be huge. Customers, regulation, margins, manufacturing needs, and time to market can all change depending on what the company is actually trying to sell.
Does the report show which Synthetic Biology companies are leading?
Yes. The Synthetic Biology market report compares major companies and shows which players are building stronger positions across different parts of the market.
We look at companies such as Ginkgo Bioworks and Twist Bioscience, along with younger businesses in more specialized categories.
The report looks at what those companies sell, how they make money, where they sit in the ecosystem, and what seems to be helping some businesses build stronger positions than others.
Market maps make it easier to compare companies side by side rather than reading a series of isolated company profiles.
In our synthetic biology market deck, we identify pain points entrepreneurs should prioritize
Does the Synthetic Biology report cover the US, Europe, and other regions?
The Synthetic Biology market report is mainly a global industry report, so buyers should expect company, technology, funding, and market analysis rather than a full country-by-country database.
The report includes companies and market activity from major synthetic biology hubs, including the US and Europe, when they are relevant to the wider market.
However, someone specifically looking for separate US market sizing, European market forecasts, or a detailed country-by-country regulatory comparison should check that the required geography is covered before buying.
We prefer to be clear about that distinction because a global Synthetic Biology industry report and a dedicated regional market study solve different research needs.
If you want more recent data on this point, please see our latest synthetic biology market report.
How long is the Synthetic Biology market report?
The Synthetic Biology market report contains 210+ pages organized across 12 sections.
The deck is long enough to cover market sizing, technologies, customers, funding, companies, business models, risks, and startup strategies in detail while still being easy to scan.
Readers can go through the whole market from start to finish or jump directly to the section they need for a competitor review, startup idea, investment discussion, or market presentation.
This chart, featured in our synthetic biology market deck, illustrates the share of revenue by region across Europe, Asia, North America, Africa, and South America in the synthetic biology market
How much does the Synthetic Biology market report cost?
The Synthetic Biology market report currently starts at $49 as a one-time purchase, with no subscription required.
The product page currently shows three options: PRO at $49, PRO+ at $79, and PRO++ at $99.
New Market Pitch also offers discounts when several reports are purchased together. The product page currently lists 20% off two reports and 30% off purchases of five reports or more.
| Option | Current price | Payment |
|---|---|---|
| PRO | $49 | One-time |
| PRO+ | $79 | One-time |
| PRO++ | $99 | One-time |
What format do I get when I buy the Synthetic Biology report?
The Synthetic Biology market report is delivered digitally in English as a structured market research deck.
The report is built for scanning, presenting, and coming back to later. Each major research question has its own section, with market maps, company comparisons, data, and analysis grouped together.
That format works well for founders researching an idea, investors reviewing a market, and strategy teams preparing internal work without having to dig through a long academic-style document.
This chart, featured in our synthetic biology market deck, illustrates yearly VC funding for synthetic biology startups
Where can I buy the latest Synthetic Biology market report?
You can buy the latest New Market Pitch Synthetic Biology Market Report directly from NewMarketPitch.com. The report is delivered digitally in English.
The current Synthetic Biology report contains 210+ pages across 12 sections and starts at $49 as a one-time purchase.
It covers the Synthetic Biology market size, technologies, startups, established companies, recent funding, investors, customer groups, business models, commercialization risks, regulation, startup failures, and the strategies stronger companies are using.
For someone looking to buy a recent Synthetic Biology market research report, a Synthetic Biology industry report in English, current Synthetic Biology market data, or the latest Synthetic Biology market report available from New Market Pitch, this is the dedicated report page.
In our synthetic biology market deck, we like to quantify things to make things easier to understand
